Ganga Pharmaceuticals Ltd.

As of March 31, 2026, Ganga Pharmaceuticals Ltd. carries a market capitalization of 70.94M, placing it among publicly traded companies globally. Its enterprise value stands at 81.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Ganga Pharmaceuticals Ltd. has 5.91M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Ganga Pharmaceuticals Ltd. maintains a current ratio of 6.12, meaning it holds 6.1x the short-term assets needed to cover near-term liabilities.

As of the close on September 8, 2026, Ganga Pharmaceuticals Ltd.'s stock has declined approximately 14.38% over the past 52 weeks. The 50-day moving average sits at 18.26, while the 200-day moving average is 11.70.

As of March 31, 2026, Ganga Pharmaceuticals Ltd. holds 582,000.00 in cash and equivalents against 10.90M in total debt, resulting in a net debt position of 10.32M. Total book value stands at 83.13M, with working capital of 63.29M providing operational flexibility.